| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |